Cleared Traditional

K101123 - NEXFIN MODEL 2

K101123 is an FDA 510(k) clearance for NEXFIN MODEL 2, manufactured by Bmeye B.V.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 189-day FDA review.

K101123 · Bmeye B.V. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2010
Decision
189d
Days
Class 2
Risk

K101123 is an FDA 510(k) clearance for the NEXFIN MODEL 2. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Bmeye B.V. (Claremont, US). The FDA issued a Cleared decision on October 28, 2010 after a review of 189 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Bmeye B.V. devices

FDA 510(k) Submission Details - K101123

510(k) Number K101123 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 2010
Decision Date October 28, 2010
Days to Decision 189 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
64d slower than avg
Panel avg: 125d · This submission: 189d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 902
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K101123.
KD-931D FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K102631 · Andon Health Co, Ltd. · Nov 2010
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K102930 · Andon Health Co, Ltd. · Nov 2010
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K102906 · Andon Health Co, Ltd. · Oct 2010
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR MODEL MD-534
K102356 · Andon Health Co, Ltd. · Sep 2010
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR MODEL KD-513
K102353 · Andon Health Co, Ltd. · Sep 2010
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR MODEL KD-930
K101950 · Andon Health Co, Ltd. · Aug 2010